Shuttle Pharmaceuticals Holdings, Inc. financial data

Symbol
SHPH on Nasdaq
Location
Gaithersburg, MD
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 224% % -2.8%
Debt-to-equity 88% % -30%
Return On Equity -476% % 18%
Return On Assets -254% % 1.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1,603,285 shares -28%
Common Stock, Shares, Outstanding 1,235,507 shares -58%
Entity Public Float $4,100,953 USD -65%
Common Stock, Value, Issued $13 USD -55%
Weighted Average Number of Shares Outstanding, Basic 2,233,650 shares 2251%
Weighted Average Number of Shares Outstanding, Diluted 2,233,650 shares 2251%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $4,529,362 USD 35%
General and Administrative Expense $4,258,331 USD 233%
Costs and Expenses $3,000,000 USD
Operating Income (Loss) $10,905,717 USD -51%
Nonoperating Income (Expense) $200,474 USD 89%
Net Income (Loss) Attributable to Parent $10,705,243 USD -17%
Earnings Per Share, Basic 56 USD/shares 97%
Earnings Per Share, Diluted 56 USD/shares 97%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $2,094,643 USD 1237%
Marketable Securities, Current $1,642,995 USD -43%
Other Assets, Current $81,534 USD
Assets, Current $3,265,913 USD 804%
Property, Plant and Equipment, Net $18,327 USD -13%
Operating Lease, Right-of-Use Asset $228,382 USD -22%
Assets $3,542,927 USD 426%
Liabilities, Current $1,964,910 USD 18%
Operating Lease, Liability, Noncurrent $175,318 USD -31%
Liabilities $2,148,766 USD 8%
Retained Earnings (Accumulated Deficit) $43,684,875 USD -32%
Stockholders' Equity Attributable to Parent $1,394,161 USD
Liabilities and Equity $3,542,927 USD 426%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $2,526,924 USD -104%
Net Cash Provided by (Used in) Financing Activities $5,119,387 USD
Net Cash Provided by (Used in) Investing Activities $101,295 USD
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 1,235,507 shares -58%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $2,592,463 USD
Interest Paid, Excluding Capitalized Interest, Operating Activities $36,153 USD
Deferred Tax Assets, Valuation Allowance $5,055,279 USD 50%
Deferred Tax Assets, Gross $5,073,442 USD 48%
Operating Lease, Liability $249,815 USD -21%
Depreciation $1,008 USD -47%
Lessee, Operating Lease, Liability, to be Paid $289,147 USD -24%
Operating Lease, Liability, Current $74,497 USD 27%
Lessee, Operating Lease, Liability, to be Paid, Year Two $99,986 USD 3%
Lessee, Operating Lease, Liability, to be Paid, Year One $97,074 USD 3%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $39,332 USD -43%
Lessee, Operating Lease, Liability, to be Paid, Year Three $68,236 USD -32%
Deferred Tax Assets, Operating Loss Carryforwards $2,996,460 USD 73%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 800,000 shares -96%
Lessee, Operating Lease, Liability, to be Paid, Year Four $68,235 USD -32%
Operating Lease, Payments $93,552 USD 3.8%
Additional Paid in Capital $45,079,023 USD 42%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense $750,075 USD 197%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%